|
| ||
|
|
||
Czech Children (czech + child)
Selected AbstractsType 1 diabetes mellitus in Czech children diagnosed in 1990,1997: a significant increase in incidence and male predominance in the age group 0,4 yearsDIABETIC MEDICINE, Issue 1 2000O. Cinek Summary Aims To overview total, age-and sex-specific incidence rates of type 1 diabetes mellitus and their trends in Czech children 0,14 years of age in the period of 1990,1997. Methods Type 1 DM cases were ascertained by two independent sources, data of general population were obtained from the annual demographic reports of the State Statistic Bureau. Incidence rates were computed using both ascertainment sources combined. Results In the study period 1.1.1990,31.12.1997, the total incidence was 10.1 (95% CI 9.6,10.6) per 100 000/year in both sexes, 10.0 (95% CI 9.4,10.7) in boys, and 10.2 (95% CI 9.5,11.0) in girls. The total age-standardized incidence was 9.9 (95% CI 9.4,10.4). The total incidence had a significant increasing trend over the study period (P = 10,4, annual increment 4.3%). A significant increasing trend was also found in the groups of children 0,4 (P = 0.033, increment 6.9%) and 5,9 years at diagnosis (P = 0.038, increment 4.8%). Statistically significant male predominance was observed in the group diagnosed at age 0,4 years (boys/girls ratio of incidence 1.33, P = 0.035). Conclusions We report the first population-based epidemiological data on incidence of childhood Type 1 DM in the Czech Republic. The incidence has increased significantly during the last 8 years. The present incidence is at an intermediate level compared to other European countries. [source] HLA class II genetic association of type 1 diabetes mellitus in Czech childrenPEDIATRIC DIABETES, Issue 3 2001Ondrej Cinek Abstract:, To examine human leukocyte antigen (HLA) class II association of type 1 diabetes mellitus (DM) in Czech children, we performed a case,control study of 261 patients diagnosed before the age of 15 and 289 non-diabetic control children. Complete HLA-DQA1, DQB1 genotyping and DRB1*04 subtyping were carried out by polymerase chain reactions with sequence-specific primers. The effect of the DRB1*04 subtypes was studied in DRB1*04 alleles carried on DQB1*0302-DQA1*03 haplotypes. The risk was statistically evaluated by testing 2 × 2 tables, considering corrected p-values <,0.05 significant. The DQB1*0302 (odds ratio, OR = 9.0), DQB1*0201 (OR = 3.4) and DQA1*03 (OR = 7.5) alleles were significantly associated with diabetes risk, while the DQB1*0602 (OR = 0.02), DQB1*0301 (OR = 0.08), DQB1*0503 (OR = 0.13), DQB1*0603 (OR = 0.20), DQA1*01 (OR = 0.28) and DQA1*02 (OR = 0.26) alleles were significantly protective. Of the DQA1-DQB1 genotypes, we point out the extremely high risk of OR = 116 conferred by HLA-DQA1*05-DQB1*0201/DQA1*03-DQB1*0302. Among DRB1*04 subtypes, DRB1*0403 was significantly protective (OR = 0.05, CI 95% 0.01,0.45). Since none of the remaining DRB1*04 subtypes was associated with type 1 DM, our study may present another piece of evidence that the DRB1*0401 and DRB1*0404 alleles do not modify type 1 diabetes risk generally in European populations. [source] | ||||||||||